Imalux Corporation

Through the use of its Niris Imaging System, Imalux Corporation offers physicians a tool to support our goal – or at least reduce the number of visits necessary to diagnose and resolve the patient's concerns. The Company's products provide real-time, high spatial resolution imaging at the point-of-care in a variety of medical applications. OCT is a new imaging modality for visualization of tissue microstructure, especially in anatomical areas with stratified tissue. It has the ability to detect near-surface tissue abnormalities indicative of many diseases, including cancer, which established imaging modalities might not detect. Niris imaging system: The Niris consists of an imaging console and a detachable fiberoptic Probe. The Imaging Console contains optical and electrical components, including a super luminescent diode (SLD). The SLD provides Near InfraRed Light (NIR), which is directed from the console through the Probe's optical fiber to the patient's tissue. The optical light is backscattered from the patient's tissue, collected by the Probe's fiber, and combined with an internal reference signal, to produce a high spatial resolution image of the superficial tissue microstructure. Probes are available in lengths up to 4 meters and are easily integrated into working channels of endoscopes.

• Employees 3
• Founded 1996
• Annual Revenue $3400000
• Total Funding $16725000